These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

322 related items for PubMed ID: 25230150

  • 1. Prognostic value of hypoxia-associated markers in advanced larynx and hypopharynx squamous cell carcinoma.
    Bernstein JM, Andrews TD, Slevin NJ, West CM, Homer JJ.
    Laryngoscope; 2015 Jan; 125(1):E8-15. PubMed ID: 25230150
    [Abstract] [Full Text] [Related]

  • 2. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
    Spector JG, Sessions DG, Haughey BH, Chao KS, Simpson J, El Mofty S, Perez CA.
    Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
    [Abstract] [Full Text] [Related]

  • 3. Overexpression of intrinsic hypoxia markers HIF1alpha and CA-IX predict for local recurrence in stage T1-T2 glottic laryngeal carcinoma treated with radiotherapy.
    Schrijvers ML, van der Laan BF, de Bock GH, Pattje WJ, Mastik MF, Menkema L, Langendijk JA, Kluin PM, Schuuring E, van der Wal JE.
    Int J Radiat Oncol Biol Phys; 2008 Sep 01; 72(1):161-9. PubMed ID: 18722267
    [Abstract] [Full Text] [Related]

  • 4. Prognostic significance of HIF-1a, CA-IX, and OPN in T1-T2 laryngeal carcinoma treated with radiotherapy.
    Wachters JE, Schrijvers ML, Slagter-Menkema L, Mastik M, de Bock GH, Langendijk JA, Kluin PM, Schuuring E, van der Laan BF, van der Wal JE.
    Laryngoscope; 2013 Sep 01; 123(9):2154-60. PubMed ID: 24167820
    [Abstract] [Full Text] [Related]

  • 5. Immunohistochemical detection of osteopontin in advanced head-and-neck cancer: prognostic role and correlation with oxygen electrode measurements, hypoxia-inducible-factor-1alpha-related markers, and hemoglobin levels.
    Bache M, Reddemann R, Said HM, Holzhausen HJ, Taubert H, Becker A, Kuhnt T, Hänsgen G, Dunst J, Vordermark D.
    Int J Radiat Oncol Biol Phys; 2006 Dec 01; 66(5):1481-7. PubMed ID: 17056190
    [Abstract] [Full Text] [Related]

  • 6. Oncological results of surgical treatment versus organ-function preservation in larynx and hypopharynx câncer.
    Calvas OIJ, Ramos DM, Matos LL, Kulcsar MAV, Dedivitis RA, Brandão LG, Cernea CR.
    Rev Assoc Med Bras (1992); 2017 Dec 01; 63(12):1082-1089. PubMed ID: 29489975
    [Abstract] [Full Text] [Related]

  • 7. Lack of prognostic effect of carbonic anhydrase-9, hypoxia inducible factor-1α and bcl-2 in 286 patients with early squamous cell carcinoma of the glottic larynx treated with radiotherapy.
    Douglas CM, Bernstein JM, Ormston VE, Hall RC, Merve A, Swindell R, Valentine HR, Slevin NJ, West CM, Homer JJ.
    Clin Oncol (R Coll Radiol); 2013 Jan 01; 25(1):59-65. PubMed ID: 22841149
    [Abstract] [Full Text] [Related]

  • 8. Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival.
    Hui EP, Chan AT, Pezzella F, Turley H, To KF, Poon TC, Zee B, Mo F, Teo PM, Huang DP, Gatter KC, Johnson PJ, Harris AL.
    Clin Cancer Res; 2002 Aug 01; 8(8):2595-604. PubMed ID: 12171890
    [Abstract] [Full Text] [Related]

  • 9. The prognostic value of the hypoxia markers CA IX and GLUT 1 and the cytokines VEGF and IL 6 in head and neck squamous cell carcinoma treated by radiotherapy +/- chemotherapy.
    De Schutter H, Landuyt W, Verbeken E, Goethals L, Hermans R, Nuyts S.
    BMC Cancer; 2005 Apr 25; 5():42. PubMed ID: 15847702
    [Abstract] [Full Text] [Related]

  • 10. Detection of the proto-oncogene eIF4E in larynx and hypopharynx cancers.
    Franklin S, Pho T, Abreo FW, Nassar R, De Benedetti A, Stucker FJ, Nathan CO.
    Arch Otolaryngol Head Neck Surg; 1999 Feb 25; 125(2):177-82. PubMed ID: 10037284
    [Abstract] [Full Text] [Related]

  • 11. The prognostic value of hypoxia markers in T2-staged oral tongue cancer.
    Roh JL, Cho KJ, Kwon GY, Ryu CH, Chang HW, Choi SH, Nam SY, Kim SY.
    Oral Oncol; 2009 Jan 25; 45(1):63-8. PubMed ID: 18620902
    [Abstract] [Full Text] [Related]

  • 12. The relation between hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha expression with anemia and outcome in surgically treated head and neck cancer.
    Winter SC, Shah KA, Han C, Campo L, Turley H, Leek R, Corbridge RJ, Cox GJ, Harris AL.
    Cancer; 2006 Aug 15; 107(4):757-66. PubMed ID: 16826581
    [Abstract] [Full Text] [Related]

  • 13. Primary tumor volume is an important predictor of clinical outcomes among patients with locally advanced squamous cell cancer of the head and neck treated with definitive chemoradiotherapy.
    Strongin A, Yovino S, Taylor R, Wolf J, Cullen K, Zimrin A, Strome S, Regine W, Suntharalingam M.
    Int J Radiat Oncol Biol Phys; 2012 Apr 01; 82(5):1823-30. PubMed ID: 21549516
    [Abstract] [Full Text] [Related]

  • 14. The relation between hypoxia and proliferation biomarkers with radiosensitivity in locally advanced laryngeal cancer.
    van den Bovenkamp K, van der Vegt B, Halmos GB, Slagter-Menkema L, Langendijk JA, van Dijk BAC, Schuuring E, van der Laan BFAM.
    Eur Arch Otorhinolaryngol; 2023 Aug 01; 280(8):3801-3809. PubMed ID: 37029804
    [Abstract] [Full Text] [Related]

  • 15. HIF-1α and CA-IX as predictors of locoregional control for determining the optimal treatment modality for early-stage laryngeal carcinoma.
    Kwon OJ, Park JJ, Ko GH, Seo JH, Jeong BK, Kang KM, Woo SH, Kim JP, Hwa JS, Carey TE.
    Head Neck; 2015 Apr 01; 37(4):505-10. PubMed ID: 24677746
    [Abstract] [Full Text] [Related]

  • 16. The prognostic value of endogenous hypoxia-related markers for head and neck squamous cell carcinomas treated with ARCON.
    Jonathan RA, Wijffels KI, Peeters W, de Wilde PC, Marres HA, Merkx MA, Oosterwijk E, van der Kogel AJ, Kaanders JH.
    Radiother Oncol; 2006 Jun 01; 79(3):288-97. PubMed ID: 16730088
    [Abstract] [Full Text] [Related]

  • 17. HIF-1alpha and CA IX staining in invasive breast carcinomas: prognosis and treatment outcome.
    Trastour C, Benizri E, Ettore F, Ramaioli A, Chamorey E, Pouysségur J, Berra E.
    Int J Cancer; 2007 Apr 01; 120(7):1451-8. PubMed ID: 17245699
    [Abstract] [Full Text] [Related]

  • 18. Progression difference between cancers of the larynx and hypopharynx is not due to tumor size and vascularization.
    Lukits J, Timár J, Juhász A, Döme B, Paku S, Répássy G.
    Otolaryngol Head Neck Surg; 2001 Jul 01; 125(1):18-22. PubMed ID: 11458208
    [Abstract] [Full Text] [Related]

  • 19. Prognostic value of total tumor volume in advanced-stage laryngeal and hypopharyngeal carcinoma.
    Yang CJ, Kim DY, Lee JH, Roh JL, Choi SH, Nam SY, Kim SY.
    J Surg Oncol; 2013 Dec 01; 108(8):509-15. PubMed ID: 24590673
    [Abstract] [Full Text] [Related]

  • 20. High serum carbonic anhydrase IX predicts shorter survival in head and neck cancer.
    Rosenberg V, Pastorekova S, Zatovicova M, Vidlickova I, Jelenska L, Slezak P.
    Bratisl Lek Listy; 2016 Dec 01; 117(4):201-4. PubMed ID: 27075382
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.